CorEvitas (formerly Corrona) Psoriasis Patient Registry

Join the CorEvitas/NPF Psoriasis Patient Registry

Help collect valuable data from psoriasis patients in a clinical setting.

 
A man speaks to a doctor at her desk in front of a computer.

The National Psoriasis Foundation and CorEvitas, LLC launched a national psoriasis patient registry in 2015. The registry collects and analyzes data from psoriasis patients in a clinical setting.

The primary objective is to use these data to study the safety of FDA-approved systemic therapies. The secondary objective is to study comparative effectiveness, including patient-reported outcomes.

The registry is seeking patients who are: 

Icon illustration of a medical document.

Diagnosis

Diagnosed with psoriasis

Icon illustration of a heart.

Age

18 or older

Icon illustration of a test tube.

Treatment

Recently started a biologic within the past 12 months (combination therapy – for example, a biologic with a topical steroid – will not disqualify someone)

Patients complete questionnaires during routine appointments with their dermatologist. Their dermatologist follows up approximately every six months. The questionnaires take about 10 to 15 minutes.

How to Contribute to the Registry:

Icon illustration of a hand and a heart.

Patients

Ask your dermatologist if he or she is currently participating in the CorEvitas Registry.

Icon illustration of a doctor.

Dermatologists

The registry is still accepting a limited number of sites for dermatologists that treat patients with moderate to severe psoriasis with systemic treatments.  Please contact CorEvitas if you are interested or have questions.

Questions or concerns?

Please reach out to us with any questions or if you are interested in participating in this program.

Contact us

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.